참고문헌 (118)

1. Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, Capra M, Goettig S, et al. 2005. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell. 123:409-421. 

   상세보기

2. Amano T, Yamasaki S, Yagishita N, Tsuchimochi K, Shin H, Kawahara K, Aratani S, Fujita H, Zhang L, Ikeda R, et al. 2003. Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev. 17:2436-2449. 

   상세보기

3. Anderson CW, Appella E. 2010. Signaling to the p53 tumor suppressor through pathways activated by genotoxic and non-genotoxic stresses. In Ralph AB, Edward AD, editors. Handbook of cell signaling. 2nd ed. San Die-go(CA): Academic Press. p. chapter 264, 2185-2204. Available from: http://www.sciencedirect.com/science/article/pii/B9780123741455002643 

4. Ashcroft M, Taya Y, Vousden KH. 2000. Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol. 20:3224-3233. 

   상세보기

5. Baert JL, Monte D, Verreman K, Degerny C, Coutte L, de Launoit Y. 2010. The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity. Oncogene. 29:1810-1820. 

   상세보기

6. Barboza JA, Iwakuma T, Terzian T, El-Naggar AK, Lozano G. 2008. Mdm2 and Mdm4 loss regulates distinct p53 activities. Mol Cancer Res. 6:947-954. 

   상세보기

7. Bargonetti J, Manfredi JJ, Chen X, Marshak DR, Prives C. 1993. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev. 7:2565-2574. 

   상세보기

8. Beitel LK, Elhaji YA, Lumbroso R, Wing SS, Panet- Raymond V, Gottlieb B, Pinsky L, Trifiro MA. 2002. Cloning and characterization of an androgen receptor Nterminal- interacting protein with ubiquitin-protein ligase activity. J Mol Endocrinol. 29:41-60. 

   상세보기

9. Bianchi E, Denti S, Catena R, Rossetti G, Polo S, Gasparian S, Putignano S, Rogge L, Pardi R. 2003. Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J Biol Chem. 278:19682-19690. 

   상세보기

10. Blagosklonny MV, Toretsky J, Neckers L. 1995. Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene 11:933-939. 

11. Brooks CL, Gu W. 2011. p53 regulation by ubiquitin. FEBS Lett. 585:2803-2809. 

    상세보기

12. Bueso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, Albitar M. 1993. The human MDM-2 oncogene is overexpressed in leukemias. Blood. 82:2617-2623. 

    상세보기

13. Chavez-Reyes A, Parant JM, Amelse LL, de Oca Luna RM, Korsmeyer SJ, Lozano G. 2003. Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets. Cancer Res. 63:8664-8669. 

    상세보기

14. Chen D, Kon N, Li M, Zhang W, Qin J, Gu W. 2005. ARFBP1/ Mule is a critical mediator of the ARF tumor suppressor. Cell. 121:1071-1083. 

    상세보기

15. Chen D, Brooks CL, Gu W. 2006. ARF-BP1 as a potential therapeutic target. Br J Cancer. 94:1555-1558. 

    상세보기

16. Chu D, Kakazu N, Gorrin-Rivas MJ, Lu HP, Kawata M, Abe T, Ueda K, Adachi Y. 2001. Cloning and characterization of LUN, a novel ring finger protein that is highly expressed in lung and specifically binds to a palindromic sequence. J Biol Chem. 276:14004-14013. 

    상세보기

17. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J, Patterson C. 2001. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol. 3:93-96. 

    상세보기

18. Coumailleau F, Das V, Alcover A, Raposo G, Vandormael- Pournin S, Le Bras S, Baldacci P, Dautry-Varsat A, Babinet C, Cohen-Tannoudji M. 2004. Over-expression of Rififylin, a new RING finger and FYVE-like domain-containing protein, inhibits recycling from the endocytic recycling compartment. Mol Biol Cell. 15: 4444-4456. 

    상세보기

19. Davidoff AM, Iglehart JD, Marks JR. 1992. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci USA. 89: 3439-3442. 

    상세보기

20. Demand J, Alberti S, Patterson C, Hohfeld J. 2001. Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling. Curr Biol. 11:1569-1577. 

    상세보기

21. Deng XW, Caspar T, Quail PH. 1991. cop1: a regulatory locus involved in light-controlled development and gene expression in Arabidopsis. Genes Dev. 5:1172-1182. 

    상세보기

22. Dornan D, Bheddah S, Newton K, Ince W, Frantz GD, Dowd P, Koeppen H, Dixit VM, French DM. 2004a. COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas. Cancer Res. 64:7226-7230. 

    상세보기

23. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM. 2004b. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 429:86-92. 

    상세보기

24. Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'Rourke K, Seshagiri S, Dixit VM. 2006. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science. 313:1122-1126. 

    상세보기

25. Duan W, Gao L, Wu X, Zhang Y, Otterson GA, Villalona- Calero MA. 2006. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells. Exp Cell Res. 312:3370-3378. 

    상세보기

26. Duan S, Yao Z, Hou D, Wu Z, Zhu WG, Wu M. 2007. Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53. EMBO J. 26:3062-3074. 

    상세보기

27. Esser C, Scheffner M, Hohfeld J. 2005. The chaperoneassociated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J Biol Chem. 280: 27443-27448. 

    상세보기

28. Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM. 2000. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem. 275:8945-8951. 

    상세보기

29. Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ. 2007. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 67:3043-3053. 

    상세보기

30. Finch RA, Donoviel DB, Potter D, Shi M, Fan A, Freed DD, Wang CY, Zambrowicz BP, Ramirez-Solis R, Sands AT, et al. 2002. mdmx is a negative regulator of p53 activity in vivo. Cancer Res. 62:3221-3225. 

    상세보기

31. Froyen G, Corbett M, Vandewalle J, Jarvela I, Lawrence O, Meldrum C, Bauters M, Govaerts K, Vandeleur L, Van Esch H, et al. 2008. Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am J Hum Genet. 82:432-443. 

    상세보기

32. Gannon JV, Greaves R, Iggo R, Lane DP. 1990. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 9:1595-1602. 

    상세보기

33. Girnita L, Girnita A, Larsson O. 2003. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc Natl Acad Sci USA. 100: 8247-8252. 

    상세보기

34. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM. 2003. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science. 300:342-344. 

    상세보기

35. Hall JR, Kow E, Nevis KR, Lu CK, Luce KS, Zhong Q, Cook JG. 2007. Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage. Mol Biol Cell. 18:3340-3350. 

    상세보기

36. Haluska P, Jr., Saleem A, Rasheed Z, Ahmed F, Su EW, Liu LF, Rubin EH. 1999. Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein. Nucleic Acids Res. 27:2538-2544. 

    상세보기

37. Hattori T, Isobe T, Abe K, Kikuchi H, Kitagawa K, Oda T, Uchida C, Kitagawa M. 2007. Pirh2 promotes ubiquitindependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. Cancer Res. 67:10789-10795. 

    상세보기

38. Haupt Y, Maya R, Kazaz A, Oren M. 1997. Mdm2 promotes the rapid degradation of p53. Nature. 387:296-299. 

    상세보기

39. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem. 67:425-479. 

    상세보기

40. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B, Levine AJ. 1990. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the ''hot spot'' mutant phenotypes. Cell Growth Differ. 1:571-580. 

41. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science. 287:1824-1827. 

    상세보기

42. Honda R, Tanaka H, Yasuda H. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25-27. 

    상세보기

43. Jain AK, Barton MC. 2010. Making sense of ubiquitin ligases that regulate p53. Cancer Biol Ther. 10:665-672. 

    상세보기

44. Jones SN, Roe AE, Donehower LA, Bradley A. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature. 378:206-208. 

    상세보기

45. Jung YS, Liu G, Chen X. 2010. Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation. Mol Cell Biol. 30:1041-1048. 

    상세보기

46. Jung YS, Qian Y, Chen X. 2011. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation. J Biol Chem. 286:35388-35395. 

    상세보기

47. Kaneko M, Ishiguro M, Niinuma Y, Uesugi M, Nomura Y. 2002. Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett. 532:147-152. 

    상세보기

48. Kato S, Ding J, Pisck E, Jhala US, Du K. 2008. COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. J Biol Chem. 283:35464-35473. 

    상세보기

49. Kim JH, Park SM, Kang MR, Oh SY, Lee TH, Muller MT, Chung IK. 2005. Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. Genes Dev. 19:776-781. 

    상세보기

50. Kruse JP, Gu W. 2009. MSL2 promotes Mdm2-independent cytoplasmic localization of p53. J Biol Chem. 284: 3250-3263. 

    상세보기

51. Kubbutat MH, Jones SN, Vousden KH. 1997. Regulation of p53 stability by Mdm2. Nature. 387:299-303. 

    상세보기

52. Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ, Roussel MF. 2003. Arf induces p53-dependent and -independent antiproliferative genes. Cancer Res. 63:1046-1053. 

    상세보기

53. Laine A, Topisirovic I, Zhai D, Reed JC, Borden KL, Ronai Z. 2006. Regulation of p53 localization and activity by Ubc13. Mol Cell Biol. 26:8901-8913. 

    상세보기

54. Laine A, Ronai Z. 2007. Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1. Oncogene. 26:1477-1483. 

    상세보기

55. Le Cam L, Linares LK, Paul C, Julien E, Lacroix M, Hatchi E, Triboulet R, Bossis G, Shmueli A, Rodriguez MS, et al. 2006. E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell. 127:775-788. 

    상세보기

56. Lee EW, Lee MS, Camus S, Ghim J, Yang MR, Oh W, Ha NC, Lane DP, Song J. 2009. Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J. 28:2100-2113. 

    상세보기

57. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S. 2003. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell. 112:779-791. 

    상세보기

58. Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W. 2003. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science. 302:1972-1975. 

    상세보기

59. Li M, Brooks CL, Kon N, Gu W. 2004. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell. 13: 879-886. 

    상세보기

60. Li DQ, Ohshiro K, Reddy SD, Pakala SB, Lee MH, Zhang Y, Rayala SK, Kumar R. 2009. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc Natl Acad Sci USA. 106:17493-17498. 

    상세보기

61. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. 2002. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 21:4037-4048. 

    상세보기

62. Lin L, Ozaki T, Takada Y, Kageyama H, Nakamura Y, Hata A, Zhang JH, Simonds WF, Nakagawara A, Koseki H. 2005. Topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage. Oncogene. 24:3385-3396. 

    상세보기

63. Liu Z, Oughtred R, Wing SS. 2005. Characterization of E3Histone, a novel testis ubiquitin protein ligase which ubiquitinates histones. Mol Cell Biol. 25:2819-2831. 

    상세보기

64. Logan IR, Gaughan L, McCracken SR, Sapountzi V, Leung HY, Robson CN. 2006. Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer. Mol Cell Biol. 26:6502-6510. 

    상세보기

65. Maruyama S, Miyajima N, Bohgaki M, Tsukiyama T, Shigemura M, Nonomura K, Hatakeyama S. 2008. Ubiquitylation of epsilon-COP by PIRH2 and regulation of the secretion of PSA. Mol Cell Biochem. 307:73-82. 

    상세보기

66. McDonald ER, 3rd, El-Deiry WS. 2004. Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proc Natl Acad Sci USA. 101:6170-6175. 

    상세보기

67. Meacham GC, Patterson C, Zhang W, Younger JM, Cyr DM. 2001. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol. 3:100-105. 

    상세보기

68. Meek DW, Anderson CW. 2009. Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol. 1:a000950. 

69. Meek DW, Knippschild U. 2003. Posttranslational modification of MDM2. Mol Cancer Res. 1:1017-1026. 

    상세보기

70. Michael D, Oren M. 2003. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol. 13:49-58. 

    상세보기

71. Migliorini D, Lazzerini Denchi E, Danovi D, Jochemsen A, Capillo M, Gobbi A, Helin K, Pelicci PG, Marine JC. 2002. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol Cell Biol. 22:5527-5538. 

    상세보기

72. Migliorini D, Bogaerts S, Defever D, Vyas R, Denecker G, Radaelli E, Zwolinska A, Depaepe V, Hochepied T, Skarnes WC, et al. 2011. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. J Clin Invest. 121:1329-1343. 

    상세보기

73. Min JN,Whaley RA, Sharpless NE, Lockyer P, Portbury AL, Patterson C. 2008. CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol Cell Biol. 28: 4018-4025. 

    상세보기

74. Nadav E, Shmueli A, Barr H, Gonen H, Ciechanover A, Reiss Y. 2003. A novel mammalian endoplasmic reticulum ubiquitin ligase homologous to the yeast Hrd1. Biochem Biophys Res Commun. 303:91-97. 

    상세보기

75. Noy T, Suad O, Taglicht D, Ciechanover A. 2012. HUWE1 ubiquitinates MyoD and targets it for proteasomal degradation. Biochem Biophys Res Commun. 418: 408-413. 

    상세보기

76. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. 1992. Amplification of a gene encoding a p53- associated protein in human sarcomas. Nature. 358: 80-83. 

    상세보기

77. Oyanagi H, Takenaka K, Ishikawa S, Kawano Y, Adachi Y, Ueda K, Wada H, Tanaka F. 2004. Expression of LUN gene that encodes a novel RING finger protein is correlated with development and progression of nonsmall cell lung cancer. Lung Cancer 46:21-28. 

    상세보기

78. Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG, Lozano G. 2001. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet. 29:92-95. 

    상세보기

79. Parsons JL, Tait PS, Finch D, Dianova II, Edelmann MJ, Khoronenkova SV, Kessler BM, Sharma RA, McKenna WG, Dianov GL. 2009. Ubiquitin ligase ARF-BP1/Mule modulates base excision repair. EMBO J. 28:3207-3215. 

    상세보기

80. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, et al. 2004. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet. 13: 703-714. 

    상세보기

81. Pickart CM. 2001. Mechanisms underlying ubiquitination. Annu Rev Biochem. 70:503-533. 

    상세보기

82. Qi L, Heredia JE, Altarejos JY, Screaton R, Goebel N, Niessen S, Macleod IX, Liew CW, Kulkarni RN, Bain J, et al. 2006. TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science. 312:1763-1766. 

    상세보기

83. Rajendra R, Malegaonkar D, Pungaliya P, Marshall H, Rasheed Z, Brownell J, Liu LF, Lutzker S, Saleem A, Rubin EH. 2004. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. J Biol Chem. 279:36440-36444. 

    상세보기

84. Rasheed ZA, Saleem A, Ravee Y, Pandolfi PP, Rubin EH. 2002. The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies. Exp Cell Res. 277:152-160. 

    상세보기

85. Renner F, Moreno R, Schmitz ML. 2010. SUMOylationdependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damagetriggered cell death. Mol Cell. 37:503-515. 

    상세보기

86. Saleem A, Dutta J, Malegaonkar D, Rasheed F, Rasheed Z, Rajendra R, Marshall H, Luo M, Li H, Rubin EH. 2004. The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor. Oncogene. 23:5293-5300. 

    상세보기

87. Sasaki S, Nakamura T, Arakawa H, Mori M, Watanabe T, Nagawa H, Croce CM. 2002. Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene. 21:5024-5030. 

    상세보기

88. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495-505. 

    상세보기

89. Sdek P, Ying H, Chang DL, Qiu W, Zheng H, Touitou R, Allday MJ, Xiao ZX. 2005. MDM2 promotes proteasome- dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell. 20:699-708. 

    상세보기

90. Sheng Y, Laister RC, Lemak A, Wu B, Tai E, Duan S, Lukin J, Sunnerhagen M, Srisailam S, Karra M, et al. 2008. Molecular basis of Pirh2-mediated p53 ubiquitylation. Nat Struct Mol Biol. 15:1334-1342. 

    상세보기

91. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ. 2001. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science. 294:1307-1313. 

    상세보기

92. Shi D, Pop MS, Kulikov R, Love IM, Kung AL, Grossman SR. 2009. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53. Proc Natl Acad Sci USA. 106:16275- 16280. 

    상세보기

93. Shieh SY, Ikeda M, Taya Y, Prives C. 1997. DNA damageinduced phosphorylation of p53 alleviates inhibition by MDM2. Cell. 91:325-334. 

    상세보기

94. Shieh SY, Taya Y, Prives C. 1999. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. 18:1815-1823. 

    상세보기

95. Shimura H, Schwartz D, Gygi SP, Kosik KS. 2004. CHIPHsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem. 279:4869-4876. 

    상세보기

96. Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M, van Ham RC, van der Houven van Oordt W, Hateboer G, van der Eb AJ, et al. 1996. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 15:5349-5357. 

    상세보기

97. Simelyte E, Rosengren S, Boyle DL, Corr M, Green DR, Firestein GS. 2005. Regulation of arthritis by p53: critical role of adaptive immunity. Arthriris Rheum. 52: 1876-1884. 

    상세보기

98. Stad R, Little NA, Xirodimas DP, Frenk R, van der Eb AJ, Lane DP, Saville MK, Jochemsen AG. 2001. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2:1029-1034. 

    상세보기

99. Sun L, Shi L, Li W, Yu W, Liang J, Zhang H, Yang X, Wang Y, Li R, Yao X, et al. 2009. JFK, a Kelch domaincontaining F-box protein, links the SCF complex to p53 regulation. Proc Natl Acad Sci USA. 106:10195-10200. 

    상세보기

100. Taira N, Yamamoto H, Yamaguchi T, Miki Y, Yoshida K. 2010. ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage. J Biol Chem. 285:4909-4919. 

     상세보기

101. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:152-157. 

     상세보기

102. Tombes RM, Mikkelsen RB, Jarvis WD, Grant S. 1999. Downregulation of delta CaM kinase II in human tumor cells. Biochim Biophys Acta. 1452:1-11. 

     상세보기

103. Vitari AC, Leong KG, Newton K, Yee C, O'Rourke K, Liu J, Phu L, Vij R, Ferrando R, Couto SS, et al. 2011. COP1 is a tumour suppressor that causes degradation of ETS transcription factors. Nature. 474:403-406. 

     상세보기

104. Wang Z, Yang B, Dong L, Peng B, He X, Liu W. 2011. A novel oncoprotein Pirh2: rising from the shadow of MDM2. Cancer Sci. 102:909-917. 

     상세보기

105. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP. 2000. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev. 14:2358-2365. 

     상세보기

106. Weger S, Hammer E, Heilbronn R. 2005. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS Lett. 579:5007-5012. 

     상세보기

107. Wei W, Kaelin WG, Jr. 2011. Good COP1 or bad COP1? In vivo veritas. J Clin Invest. 121:1263-1265. 

     상세보기

108. Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ, Dixit VM. 2004. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science. 303:1371-1374. 

     상세보기

109. Whitesell L, Sutphin PD, Pulcini EJ, Martinez JD, Cook PH. 1998. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol. 18:1517-1524. 

     상세보기

110. Wu H, Zeinab RA, Flores ER, Leng RP. 2011. Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination. Mol Cancer Res. 9:1780-1790. 

     상세보기

111. Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L. 2002. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc Natl Acad Sci USA. 99:12847-12852. 

     상세보기

112. Yamasaki S, Yagishita N, Sasaki T, Nakazawa M, Kato Y, Yamadera T, Bae E, Toriyama S, Ikeda R, Zhang L, et al. 2007. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J. 26:113-122. 

     상세보기

113. Yang W, Rozan LM, McDonald ER, 3rd, Navaraj A, Liu JJ, Matthew EM, Wang W, Dicker DT, El-Deiry WS. 2007. CARPs are ubiquitin ligases that promote MDM2- independent p53 and phospho-p53ser20 degradation. J Biol Chem. 282:3273-3281. 

     상세보기

114. Yi C, Wang H, Wei N, Deng XW. 2002. An initial biochemical and cell biological characterization of the mammalian homologue of a central plant developmental switch, COP1. BMC Cell Biol. 3:30. 

     상세보기

115. Yoon SY, Lee Y, Kim JH, Chung AS, Joo JH, Kim CN, Kim NS, Choe IS, Kim JW. 2005. Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein. Biochem Biophys Res Commun. 326:7-17. 

116. Zhang Y, Xiong Y, Yarbrough WG. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92:725-734. 

     상세보기

117. Zhang Z, Wang H, Li M, Agrawal S, Chen X, Zhang R. 2004. MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J Biol Chem. 279:16000-16006. 

     상세보기

118. Zhong Q, Gao W, Du F, Wang X. 2005. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell. 121:1085-1095. 

     상세보기

저자의 다른 논문 :

정진하 (9)